Japan To Experiment With New NHI Drug Pricing Policy In FY 2010
This article was originally published in PharmAsia News
Executive Summary
TOKYO - A new National Health Insurance drug pricing system that secures prices during patent protection periods but lowers listing prices substantially upon patent expiration will start on an experimental basis beginning April 1